ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Cipher Pharmaceuticals Inc

Cipher Pharmaceuticals Inc (CPH)

14,69
0,23
(1,59%)
Geschlossen 22 Dezember 10:12PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
14,69
Gebot
14,10
Fragen
14,91
Volumen
21.882
14,40 Tagesbereich 14,88
5,35 52-Wochen-Bereich 19,69
Marktkapitalisierung
Handelsende
14,46
Handelsbeginn
14,42
Letzte Trade
76
@
14.69
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
52.987
Ausgegebene Aktien
23.988.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
17,12
Gewinn pro Aktie (EPS)
0,85
Erlöse
21,16M
Nettogewinn
20,38M

Über Cipher Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Oakville, Ontario, Can
Gegründet
-
Cipher Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker CPH. The last closing price for Cipher Pharmaceuticals was $14,46. Over the last year, Cipher Pharmaceuticals shares have traded in a share price range of $ 5,35 to $ 19,69.

Cipher Pharmaceuticals currently has 23.988.000 shares in issue. The market capitalisation of Cipher Pharmaceuticals is $346,87 million. Cipher Pharmaceuticals has a price to earnings ratio (PE ratio) of 17.12.

CPH Neueste Nachrichten

OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX

NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cipher...

Cipher Pharmaceuticals Reports Voting Results for the Election of Directors

MISSISSAUGA, Ontario, June 12, 2019 (GLOBE NEWSWIRE) -- Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company"), in accordance with Toronto Stock Exchange requirements, announced today...

Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical sol...

The agreement will expand the availability of the first and only U.S. FDA-approved prescription product for the treatment of raised seborrheic keratoses (SKs) WAYNE, Pa., April 06, 2018...

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome PR Newswire MISSISSAUGA, ON, and VANCOUVER, March 20, 2018 Cipher to Acquire...

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy Pharmaceuticals PR Newswire MISSISSAUGA, ON, Feb. 28, 2018 A new differentiated treatment...

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III...

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III Study PR Newswire PETACH TIKVA, Israel, May 16, 2017 PETACH TIKVA...

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ

Cipher Pharmaceuticals Announces Plans to Voluntarily Delist from NASDAQ PR Newswire MISSISSAUGA, ON, Nov. 29, 2016 MISSISSAUGA, ON, Nov. 29, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc...

Cipher Pharmaceuticals Reports Q3 2016 Financial Results

Cipher Pharmaceuticals Reports Q3 2016 Financial Results PR Newswire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR;...

Cipher Pharmaceuticals Announces Management Change

Cipher Pharmaceuticals Announces Management Change PR Newswire MISSISSAUGA, ON, Nov. 11, 2016 MISSISSAUGA, ON, Nov. 11, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH...

Cipher Pharmaceuticals Responds to Request for Comment from IIROC

Cipher Pharmaceuticals Responds to Request for Comment from IIROC PR Newswire MISSISSAUGA, ON, Oct. 31, 2016 MISSISSAUGA, ON, Oct. 31, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.886.3721940622713.8114.8813.772888414.24104958CS
40.231.5905947441214.4616.2913.774079414.8391889CS
121.319.7907324364713.3818.3612.535298714.88328777CS
266.3676.35054021618.3319.698.016092814.50800527CS
528.8149.4057724965.8919.695.354723112.19904875CS
15613.1823.8993710691.5919.691.57318897.61659079CS
26013.691369119.690.38383774.44465715CS

CPH - Frequently Asked Questions (FAQ)

What is the current Cipher Pharmaceuticals share price?
The current share price of Cipher Pharmaceuticals is $ 14,69
How many Cipher Pharmaceuticals shares are in issue?
Cipher Pharmaceuticals has 23.988.000 shares in issue
What is the market cap of Cipher Pharmaceuticals?
The market capitalisation of Cipher Pharmaceuticals is CAD 346,87M
What is the 1 year trading range for Cipher Pharmaceuticals share price?
Cipher Pharmaceuticals has traded in the range of $ 5,35 to $ 19,69 during the past year
What is the PE ratio of Cipher Pharmaceuticals?
The price to earnings ratio of Cipher Pharmaceuticals is 17,12
What is the cash to sales ratio of Cipher Pharmaceuticals?
The cash to sales ratio of Cipher Pharmaceuticals is 16,49
What is the reporting currency for Cipher Pharmaceuticals?
Cipher Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Cipher Pharmaceuticals?
The latest annual turnover of Cipher Pharmaceuticals is USD 21,16M
What is the latest annual profit for Cipher Pharmaceuticals?
The latest annual profit of Cipher Pharmaceuticals is USD 20,38M
What is the registered address of Cipher Pharmaceuticals?
The registered address for Cipher Pharmaceuticals is 209 OAK PARK BLVD., SUITE 501, OAKVILLE, ONTARIO, L6H 0M2
What is the Cipher Pharmaceuticals website address?
The website address for Cipher Pharmaceuticals is www.cipherpharma.com
Which industry sector does Cipher Pharmaceuticals operate in?
Cipher Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
APSAptose Biosciences Inc
$ 0,42
(75,00%)
30,28k
RTGRTG Mining Inc
$ 0,04
(60,00%)
3k
BNGBengal Energy Ltd
$ 0,015
(50,00%)
1.000
BBBlackBerry Limited
$ 5,29
(23,60%)
13,59M
ARAAclara Resources Inc
$ 0,495
(17,86%)
27,19k
BABYElse Nutrition Holdings Inc
$ 0,01
(-33,33%)
190k
DIAMStar Diamond Corporation
$ 0,015
(-25,00%)
2,34M
KRNKarnalyte Resources Inc
$ 0,085
(-19,05%)
20,5k
STEPSTEP Energy Services Ltd
$ 4,18
(-14,87%)
283,69k
SBISerabi Gold Plc
$ 2,13
(-11,62%)
73,81k
CNQCanadian Natural Resources Ltd
$ 42,49
(0,02%)
18,71M
TRPTC Energy Corporation
$ 65,77
(0,84%)
17,86M
CMCanadian Imperial Bank of Commerce
$ 92,48
(0,75%)
16,28M
MFCManulife Financial Corporation
$ 43,54
(0,48%)
14,47M
BBBlackBerry Limited
$ 5,29
(23,60%)
13,59M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock